PBA Stock Analysis: Pembina Pipeline | NYSE
Oil & Gas Midstream | NYSE, USA | Market Cap: 27.444m USD | 12M Return: 28.7% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 66.2M
EPS Trend: -21.8%
Qual. Beats: 0
Rev. Trend: -52.9%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Pembina Pipeline Corporation (NYSE: PBA) is a Calgary-based Canadian energy transportation and midstream services provider founded in 1954, operating across North America through three core segments. The Pipelines segment transports crude oil, natural gas liquids (NGLs), and natural gas across Western Canada and other North American markets via conventional, oil sands, and transmission pipeline systems. The Facilities segment provides processing, fractionation, storage, and terminalling infrastructure for crude oil, natural gas, NGLs (including ethane, propane, and butane), and condensate. The Marketing & New Ventures segment purchases and resells hydrocarbon liquids and natural gas sourced primarily from the Western Canadian Sedimentary Basin.
As a midstream operator, Pembina occupies the critical link between upstream production (extraction) and downstream refining or end-use markets, typically generating revenue through long-term, fee-based contracts that reduce direct commodity price exposure. The companys services include NGL fractionation, cavern storage, and export terminalling, which are essential infrastructure for moving hydrocarbons from production basins to refineries, petrochemical plants, and export markets.
- Oil sands throughput drives fee-based pipeline segment revenue
- NGL fractionation margins rise on Western Canadian LPG export demand
- Capital allocation shifts toward gas processing acquisition and debt reduction
| Net Income: 1.69b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.41 > 1.0 |
| NWC/Revenue: -4.54% < 20% (prev -9.87%; Δ 5.33% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.79b > Net Income 1.69b |
| Net Debt (14.4b) to EBITDA (3.69b): 3.90 < 3 |
| Current Ratio: 0.83 > 1.5 & < 3 |
| Outstanding Shares: last quarter (582.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 40.46% > 18% (prev 43.08%; Δ -2.62% > 0.5%) |
| Asset Turnover: 21.03% > 50% (prev 22.84%; Δ -1.81% > 0%) |
| Interest Coverage Ratio: 4.44 > 6 (EBIT TTM 2.70b / Interest Expense TTM 607.4m) |
| A: -0.01 (Total Current Assets 1.72b - Total Current Liabilities 2.06b) / Total Assets 36.3b |
| B: -0.06 (Retained Earnings -2.33b / Total Assets 36.3b) |
| C: 0.08 (EBIT TTM 2.70b / Avg Total Assets 36.0b) |
| D: 0.88 (Book Value of Equity 16.9b / Total Liabilities 19.3b) |
| Altman-Z'' = 1.15 = BB |
| DSRI: 1.33 (Receivables 1.21b/978.0m, Revenue 7.57b/8.16b) |
| GMI: 1.06 (GM 43.08% / 40.46%) |
| AQI: 1.01 (AQ_t 0.31 / AQ_t-1 0.31) |
| SGI: 0.93 (Revenue 7.57b / 8.16b) |
| TATA: -0.03 (NI 1.69b - CFO 2.79b) / TA 36.3b) |
| Beneish M = -2.74 (Cap -4..+1) = A |
As of July 02, 2026, the stock is trading at USD 46.25 with a total of 467,733 shares traded. Over the past week, the price has changed by -1.46%, over one month by -2.62%, over three months by +5.86% and over the past year by +28.73%.
Current recommended Stop Loss: 44.30 (which is 4.2% or 2 ATR below the current price).
Pembina Pipeline has received a consensus analysts rating of 4.17. Therefore, it is recommended to buy PBA.
- StrongBuy: 8
- Buy: 5
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 40.6 | -12.2% |
Market Cap CAD = 39.0b (27.4b USD * 1.4211 USD.CAD)
P/E Trailing = 25.2406
P/E Forward = 22.5225
P/S = 3.6101
P/B = 2.5752
P/EG = 2.8349
Revenue TTM = 7.57b CAD
EBIT TTM = 2.70b CAD
EBITDA TTM = 3.69b CAD
Long Term Debt = 12.7b CAD (from longTermDebt, last quarter)
Short Term Debt = 682.8m CAD (from shortTermDebt, last quarter)
Debt = 14.6b CAD (from shortLongTermDebtTotal, last quarter) + Leases 607.0m
Net Debt = 14.4b CAD (calculated: Debt 14.6b - CCE 173.4m)
Enterprise Value = 53.4b CAD (39.0b + Debt 14.6b - CCE 173.4m)
Interest Coverage Ratio = 4.44 (Ebit TTM 2.70b / Interest Expense TTM 607.4m)
EV/FCF = 26.93x (Enterprise Value 53.4b / FCF TTM 1.98b)
FCF Yield = 3.71% (FCF TTM 1.98b / Enterprise Value 53.4b)
FCF Margin = 26.20% (FCF TTM 1.98b / Revenue TTM 7.57b)
Net Margin = 22.35% (Net Income TTM 1.69b / Revenue TTM 7.57b)
Gross Margin = 40.46% ((Revenue TTM 7.57b - Cost of Revenue TTM 4.51b) / Revenue TTM)
Gross Margin QoQ = 38.48% (prev 43.23%)
Tobins Q-Ratio = 1.47 (Enterprise Value 53.4b / Total Assets 36.3b)
Interest Expense / Debt = 4.17% (Interest Expense 607.4m / Debt 14.6b)
Taxrate = 23.15% (509.3m / 2.20b)
NOPAT = 2.07b (EBIT 2.70b * (1 - 23.15%))
Current Ratio = 0.83 (Total Current Assets 1.72b / Total Current Liabilities 2.06b)
Debt / Equity = 0.86 (Debt 14.6b / totalStockholderEquity, last quarter 16.9b)
Debt / EBITDA = 3.90 (Net Debt 14.4b / EBITDA 3.69b)
Debt / FCF = 7.26 (Net Debt 14.4b / FCF TTM 1.98b)
Total Stockholder Equity = 16.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.70% (Net Income 1.69b / Total Assets 36.3b)
RoE = 9.98% (Net Income TTM 1.69b / Total Stockholder Equity 16.9b)
RoCE = 9.11% (EBIT 2.70b / Capital Employed (Equity 16.9b + L.T.Debt 12.7b))
RoIC = 5.98% (NOPAT 2.07b / Invested Capital 34.7b)
WACC = 5.29% (E(39.0b)/V(53.6b) * Re(6.07%) + D(14.6b)/V(53.6b) * Rd(4.17%) * (1-Tc(0.23)))
Discount Rate = 6.07% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 78.88 | Cagr: 2.55%
[DCF] Terminal Value 74.66% ; FCFF base≈2.03b ; Y1≈1.94b ; Y5≈1.87b
[DCF] Fair Price = 25.84 (EV 29.4b - Net Debt 14.4b = Equity 15.0b / Shares 581.4m; r=8.35% [WACC [floored]]; 5y FCF grow -5.55% → 2.50% )
EPS Correlation: -21.83 | EPS CAGR: -6.30% | SUE: 0.28 | # QB: 0
Revenue Correlation: -52.89 | Revenue CAGR: -2.17% | SUE: 0.60 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.69 | Chg30d=+0.82% | Revisions=+50% | Analysts=4
EPS current Year (2026-12-31): EPS=3.01 | Chg30d=+0.84% | Revisions=+67% | GrowthEPS=+17.0% | GrowthRev=+12.5%
EPS next Year (2027-12-31): EPS=3.05 | Chg30d=-0.43% | Revisions=+17% | GrowthEPS=+1.3% | GrowthRev=+2.9%
[Analyst] Revisions Ratio: +67%